Fidia completes establishment of its operations and seeks further growth opportunities in North America
PARSIPPANY, N.J. & ABANO TERME, Italy July 07, 2014 -- Fidia Pharma USA Inc., a wholly-owned subsidiary of Fidia Farmaceutici SpA, an international integrated company and recognized leader in hyaluronic acid-based products, announced today the completion of the establishment of its operations in the United States.
Effective July 2014, the company's sales force, previously operating under
FIDIA Farmaceutici to Attend the 32nd Annual J.P. Morgan Investors Healthcare Conference
ABANO TERME, Italy and PARSIPPANY, New Jersey, January 6, 2014 /PRNewswire/ --
FIDIA Farmaceutici S.p.A., the Italian pharmaceutical company leader in hyaluronic acid (HY) - based products, announced today that they will be present at the 32nd Annual J. P. Morgan Investors Healthcare Conference. The conference will take place on Monday, January 13, 2014, through Thursday,